Related Experiment Videos

Identifying drug resistant cancer cells using microbubble well arrays

Qihui Pu1, Ryan Spooner1, Lisa A DeLouise2,3

  • 1Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.

Insights

Microbubble well arrays effectively identify and culture drug-resistant cancer cells, including stem cell markers. This technology aids in developing personalized cancer treatment strategies against metastatic disease.

Area of Science:

  • Oncology
  • Biotechnology
  • Cell Biology

Background:

  • Drug resistance in tumor-initiating cells drives metastatic disease.
  • Standard cell culture methods may not adequately support the study of resistant cell populations.

Purpose of the Study:

  • To evaluate microbubble well arrays as a platform for enumerating and characterizing drug-resistant cancer cells.
  • To explore the potential of this technology for developing patient-specific treatment strategies.

Main Methods:

  • Utilized microbubble well arrays for culturing a human squamous cell carcinoma line.
  • Assessed cell survival, clonal proliferation, sphere formation, and expression of stem cell markers (CD44, CD133).
  • Applied the platform to cellularized primary human tumors.

Main Results:

  • Microbubble wells supported single-cell survival, clonal proliferation, and sphere formation resistant to cisplatin.
  • Formed spheres showed positive staining for CD44 and CD133.
  • Spheres were also observed in cultured primary human tumors.

Conclusions:

  • Microbubble array technology can enumerate drug-resistant cancer cells and facilitate testing of drug combinations.
  • This platform holds promise for designing personalized cancer therapies and understanding metastatic disease mechanisms.

Related Concept Videos